A Sweet Approach to Heat Up Cancer Response to Immunotherapy.
Oliver M T PearceHeinz LaubliPublished in: Cancer discovery (2021)
Song and colleagues describe how N-glycans stabilize expression of checkpoint molecule B7-H4 that suppresses T-cell function. Inhibiting N-glycan stabilization of B7-H4 generates an immune hot cancer that is more responsive to combination therapies.See related article by Song et al., p. 1872.